An act relating to limiting out-of-pocket expenses for prescription insulin drugs
Bill status
passed
3 of 5 stages cleared
Introduction
Jan 2020
Committee Review
Mar 2020
Senate Passage
Mar 2020
House Passage
Governor
Introduced Jan 15, 2020
Last action Mar 13, 2020
Floor votes
How they voted
This bill passed the Senate. No roll call record of that vote is available.
Full legislative history
Actions timeline
Total actions
14
Key actions
5
Committee
5
Mar 13, 2020
Committee
Referred to the Committee on Health Care
lower
Mar 11, 2020
Upper · Passed
Read 3rd time & passed
upper
Feb 28, 2020
Upper · Passed
Recommendation of amendment by Committee on Finance agreed to
upper
Feb 28, 2020
Upper · Passed
Favorable report with recommendation of amendment by Committee on Finance
upper
Feb 27, 2020
Upper · Passed
Favorable report with recommendation of amendment by Committee on Finance
upper
Feb 26, 2020
Upper · Passed
Favorable report with recommendation of amendment by Committee on Finance
upper
Jan 15, 2020
Introduced
Read 1st time & referred to Committee on Finance
upper
1 primary · 2 co-sponsors
Sponsors
Role
Legislator
Party
State
District
P
CH
Cheryl Hooker
DDemocratic/Progressive
Co
Alison Clarkson
DDemocratic
Co
Ruth Hardy
DDemocratic
Ask Maddy
·
AI policy assistant
Ask Maddy about S 296
Scope: VT
Hi! I can help you understand S 296. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline